Divya Goel, MBS of Celltheon Corporation discusses the role of Allegro™ STR single-use bioreactors in meeting the changing monoclonal antibody (mAb) bioprocessing challenges and to avoid operating inefficiencies in the future. Learn more at https://biotech.pall.com/en/cell-culture/stirred-tank-bioreactors.html
